See more : Sambhaav Media Limited (SAMBHAAV.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Neptune Wellness Solutions Inc. (NEPTF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Neptune Wellness Solutions Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS) Income Statement Analysis – Financial Results
- Tripadvisor, Inc. (TRIP) Income Statement Analysis – Financial Results
- Mitsu Chem Plast Limited (MITSU.BO) Income Statement Analysis – Financial Results
- KPI Green Energy Limited (KPIGREEN.NS) Income Statement Analysis – Financial Results
- Bank of America Corporation (BML-PL) Income Statement Analysis – Financial Results
Neptune Wellness Solutions Inc. (NEPTF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.neptunecorp.com
About Neptune Wellness Solutions Inc.
Neptune Wellness Solutions Inc. operates as a consumer packaged goods company in Canada, the United States, and internationally. It's product portfolio includes omega-3 fish oils and other nutritional products, as well as softgel solutions under the Biodroga brand; and provides MaxSimil, an omega-3 fatty acid delivery technology that uses enzymes to predigest omega-3 fatty acids. The company offers vegan multi-omega gummies and soft gels under the Forest Remedies brand; and organic baby food products under the Sprout brands. It offers its products through distributors, retail outlets, and grocery stores, as well as online on forestremedies.com and sproutorganics.com, and e-commerce sites. Neptune Wellness Solutions Inc. was incorporated in 1998 and is headquartered in Laval, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 52.62M | 48.80M | 35.41M | 22.23M | 18.63M | 21.54M | 32.92M | 17.32M |
| Cost of Revenue | 57.51M | 60.85M | 78.86M | 27.65M | 15.16M | 18.54M | 25.01M | 14.21M |
| Gross Profit | -4.90M | -12.06M | -43.46M | -5.42M | 3.47M | 3.00M | 7.91M | 3.11M |
| Gross Profit Ratio | -9.31% | -24.71% | -122.74% | -24.39% | 18.65% | 13.93% | 24.03% | 17.94% |
| Research & Development | 484.22K | 880.15K | 1.64M | 2.21M | 3.94M | 8.63M | 3.34M | 5.01M |
| General & Administrative | 0.00 | 0.00 | 89.34M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | -39.28M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 44.00M | 57.04M | 50.06M | 42.57M | 10.94M | 10.56M | 11.07M | 10.28M |
| Other Expenses | 53.47M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 100.37M | 57.92M | 51.70M | 44.78M | 14.88M | 19.19M | 14.41M | 15.29M |
| Cost & Expenses | 155.46M | 118.78M | 130.57M | 72.43M | 30.04M | 37.73M | 39.42M | 29.50M |
| Interest Income | 1.45K | 7.12K | 38.33K | 106.63K | 178.90K | 177.23K | 46.79K | 81.38K |
| Interest Expense | 2.32M | 1.54M | 916.09K | 411.58K | 346.92K | 1.76M | 1.94M | 1.11M |
| Depreciation & Amortization | 2.73M | 6.08M | 19.42M | 6.30M | 2.33M | 2.76M | 2.68M | 1.97M |
| EBITDA | -83.87M | -76.80M | -107.76M | -43.90M | -14.93M | 11.88M | 5.92M | -6.98M |
| EBITDA Ratio | -159.41% | -130.95% | -213.91% | -197.52% | -48.72% | -62.35% | -11.58% | -58.94% |
| Operating Income | -102.85M | -69.98M | -95.16M | -50.20M | -11.41M | -16.19M | -6.50M | -12.18M |
| Operating Income Ratio | -195.47% | -143.41% | -268.76% | -225.86% | -61.23% | -75.16% | -19.74% | -70.34% |
| Total Other Income/Expenses | 14.05M | -14.45M | -35.85M | 7.87M | -6.20M | 22.15M | 8.67M | 2.13M |
| Income Before Tax | -88.80M | -84.42M | -131.02M | -42.33M | -17.61M | 7.36M | 2.18M | -10.06M |
| Income Before Tax Ratio | -168.78% | -173.01% | -370.03% | -190.47% | -94.53% | 34.19% | 6.61% | -58.06% |
| Income Tax Expense | 0.00 | -9.45M | -3.49M | 3.40M | 66.64K | 87.07K | 1.56M | -1.77M |
| Net Income | -60.46M | -74.97M | -126.43M | -45.74M | -17.68M | 13.66M | 4.86M | -5.72M |
| Net Income Ratio | -114.91% | -153.64% | -357.08% | -205.77% | -94.88% | 63.41% | 14.77% | -33.01% |
| EPS | -5.12 | -15.54 | -36.49 | -17.79 | -7.78 | 6.08 | 2.18 | -2.64 |
| EPS Diluted | -5.12 | -15.54 | -36.49 | -17.79 | -7.78 | 6.02 | 2.18 | -2.64 |
| Weighted Avg Shares Out | 11.81M | 4.82M | 3.47M | 2.57M | 2.27M | 2.25M | 2.23M | 2.16M |
| Weighted Avg Shares Out (Dil) | 11.81M | 4.82M | 3.47M | 2.57M | 2.27M | 2.27M | 2.23M | 2.16M |
Source: https://incomestatements.info
Category: Stock Reports